{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:37:14Z","timestamp":1761172634637,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.mycmed.2022.101259","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T02:17:40Z","timestamp":1645755460000},"page":"101259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel method for predicting the efficacy of topical drugs on onychomycosis: A comparison of efinaconazole and luliconazole"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1715-9176","authenticated-orcid":false,"given":"Akane","family":"Masumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mycmed.2022.101259_bib0001","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1610-0387.2007.06180.x","article-title":"Trichophyton mentagrophytes sive interdigitale? a dermatophyte in the course of time","volume":"5","author":"Nenoff","year":"2007","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.mycmed.2022.101259_bib0002","series-title":"Scher and Daniel's nails","first-page":"153","article-title":"Onychomycosis: clinical aspects","author":"Gupta","year":"2018"},{"issue":"4","key":"10.1016\/j.mycmed.2022.101259_bib0003","first-page":"186","article-title":"Comparison of therapeutic efficacy between lateral type of distal and lateral subungual onychomycosis (DLSO) and non-lateral types of DLS","volume":"16","author":"Bang","year":"2011","journal-title":"Korean J Med Mycol"},{"issue":"7","key":"10.1016\/j.mycmed.2022.101259_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159661","article-title":"Efficacy coefficients determined using nail permeability and antifungal activity in keratin-containing media are useful for predicting clinical efficacies of topical drugs for onychomycosis","volume":"11","author":"Matsuda","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.mycmed.2022.101259_bib0005","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1128\/AAC.00111-14","article-title":"The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment","volume":"58","author":"Sugiura","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.mycmed.2022.101259_bib0006","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.2042-7158.1997.tb06127.x","article-title":"In-vitro permeability of the human nail and of a keratin membrane from bovine hooves: prediction of the penetration rate of antimycotics through the nail plate and their efficacy","volume":"49","author":"Mertin","year":"1997","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"10.1016\/j.mycmed.2022.101259_bib0007","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00779-17","article-title":"In vitro human onychopharmacokinetic and pharmacodynamic analyses of ME1111, a new topical agent for onychomycosis","volume":"62","author":"Kubota-Ishida","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.mycmed.2022.101259_bib0008","doi-asserted-by":"crossref","first-page":"J141","DOI":"10.3314\/mmj.16-00020","article-title":"Comparison of characteristics of two topical therapeutic agents for onychomycosis","volume":"7","author":"Shimamura","year":"2016","journal-title":"Med Mycol J"},{"key":"10.1016\/j.mycmed.2022.101259_bib0009","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-3-540-79307-6_13","article-title":"Clinical aspects of dermatophyte infections","volume":"6","author":"Brasch","year":"2008","journal-title":"Hum Anim Relatsh"},{"issue":"2","key":"10.1016\/j.mycmed.2022.101259_bib0010","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/iai.18.2.479-486.1977","article-title":"Factors affecting germination of Trichophyton mentagrophytes arthrospores","volume":"18","author":"Hashimoto","year":"1977","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.mycmed.2022.101259_bib0011","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/jac\/dkn245","article-title":"In vitro antifungal drug susceptibilities of dermatophytes microconidia and arthroconidia","volume":"62","author":"Coelho","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"S1","key":"10.1016\/j.mycmed.2022.101259_bib0012","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/CDR.CDR_34_17","article-title":"Topical antifungals: a review and their role in current management of dermatophytoses","volume":"1","author":"Poojary","year":"2017","journal-title":"Clin Dermatol Rev"},{"issue":"3","key":"10.1016\/j.mycmed.2022.101259_bib0013","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/mmy\/myaa111","article-title":"A comparative study between two antifungal agents, luliconazole and efinaconazole, of their preventive effects in a Trichophyton-infected guinea pig onychomycosis model","volume":"59","author":"Nakamura","year":"2021","journal-title":"Med Mycol"},{"issue":"3","key":"10.1016\/j.mycmed.2022.101259_bib0014","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3314\/jjmm1960.27.175","article-title":"A simple and reliable culturing method for production of arthrospores by dermatophytes","volume":"27","author":"Fujita","year":"1986","journal-title":"Jpn J Med Mycol"},{"issue":"4","key":"10.1016\/j.mycmed.2022.101259_bib0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/jof3040058","article-title":"Fungicidal activity in the presence of keratin as an important factor contributing to in vivo efficacy: a comparison of efinaconazole, tavaborole, and ciclopirox","volume":"3","author":"Tachibana","year":"2017","journal-title":"J Fungi"},{"issue":"1","key":"10.1016\/j.mycmed.2022.101259_bib0016","doi-asserted-by":"crossref","first-page":"J7","DOI":"10.3314\/mmj.57.J7","article-title":"Affinity of luliconazole to keratin prepared from healthy human nailand porcine hoof","volume":"57","author":"Hasuko","year":"2016","journal-title":"Med Mycol J"},{"issue":"1\u20132","key":"10.1016\/j.mycmed.2022.101259_bib0017","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijpharm.2008.01.027","article-title":"Chemical method to enhance transungual transport and iontophoresis efficiency","volume":"357","author":"Hao","year":"2008","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.mycmed.2022.101259_bib0018","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaad.2012.10.013","article-title":"Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies","volume":"68","author":"Elewski","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.mycmed.2022.101259_bib0019","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/1346-8138.13816","article-title":"Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: a multicenter, double-blind, randomized phase III study","volume":"44","author":"Watanabe","year":"2017","journal-title":"J Dermatol"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523322000166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523322000166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:21:18Z","timestamp":1761110478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523322000166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1156523322000166"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2022.101259","relation":{},"ISSN":["1156-5233"],"issn-type":[{"type":"print","value":"1156-5233"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel method for predicting the efficacy of topical drugs on onychomycosis: A comparison of efinaconazole and luliconazole","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2022.101259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS on behalf of SFMM.","name":"copyright","label":"Copyright"}],"article-number":"101259"}}